PARP1 c.794T>C ;(p.L265P)

Variant ID: 1-226574067-A-G

NM_001618.3(PARP1):c.794T>C;(p.L265P)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.

Oncotarget
Mondello, Patrizia P; Derenzini, Enrico E; Asgari, Zahra Z; Philip, John J; Brea, Elliott J EJ; Seshan, Venkatraman V; Hendrickson, Ronald C RC; de Stanchina, Elisa E; Scheinberg, David A DA; Younes, Anas A
Publication Date: 2017-02-21

Variant appearance in text: PARP: L265P
PubMed Link: 28147336
Variant Present in the following documents:
  • Main text
  • oncotarget-08-14017.pdf
View BVdb publication page